Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca Rocca

Showing results (11-20 of 156) with videos related to

Pageof 16
Sort By:
European Cardiology|March 16, 2026
ADAPT AF-DES and the Limits of Non-inferiority in Long-term Antithrombotic TherapyMassimo Grimaldi, Bianca Rocca
Molecular Interventions|February 4, 2010
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of responseBianca Rocca, Giovanna Petrucci
Research and Practice in Thrombosis and Haemostasis|May 22, 2023
Precision antiplatelet therapyBianca Rocca, Carlo Patrono
Cardiovascular Research|April 1, 2021
Platelets, coagulation, and the vascular wall: the quest to better understand and smarten up our therapeutic targeting of this triad in primary and secondary prevention of cardiovascular eventsBianca Rocca, Karlheinz Peter
Pharmacological Research|May 7, 2009
Nonsteroidal antiinflammatory drugs: past, present and futureCarlo Patrono, Bianca Rocca
Journal of the American College of Cardiology|January 17, 2017
Type 2 Diabetes, Obesity, and Aspirin ResponsivenessCarlo Patrono, Bianca Rocca
Handbook of Experimental Pharmacology|August 25, 2012
Aspirin and Other COX-1 inhibitorsCarlo Patrono, Bianca Rocca
Nature Clinical Practice. Cardiovascular Medicine|December 21, 2006
Drug insight: aspirin resistance--fact or fashion?Carlo Patrono, Bianca Rocca
Diabetes Research and Clinical Practice|January 12, 2020
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspectiveBianca Rocca, Carlo Patrono
Research and Practice in Thrombosis and Haemostasis|June 7, 2021
Aspirin at 120: Retiring, recombining, or repurposing?Carlo Patrono, Bianca Rocca
Pageof 16

Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
European Cardiology|March 16, 2026
ADAPT AF-DES and the Limits of Non-inferiority in Long-term Antithrombotic TherapyMassimo Grimaldi, Bianca Rocca
Molecular Interventions|February 4, 2010
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of responseBianca Rocca, Giovanna Petrucci
Research and Practice in Thrombosis and Haemostasis|May 22, 2023
Precision antiplatelet therapyBianca Rocca, Carlo Patrono
Cardiovascular Research|April 1, 2021
Platelets, coagulation, and the vascular wall: the quest to better understand and smarten up our therapeutic targeting of this triad in primary and secondary prevention of cardiovascular eventsBianca Rocca, Karlheinz Peter
Pharmacological Research|May 7, 2009
Nonsteroidal antiinflammatory drugs: past, present and futureCarlo Patrono, Bianca Rocca
Journal of the American College of Cardiology|January 17, 2017
Type 2 Diabetes, Obesity, and Aspirin ResponsivenessCarlo Patrono, Bianca Rocca
Handbook of Experimental Pharmacology|August 25, 2012
Aspirin and Other COX-1 inhibitorsCarlo Patrono, Bianca Rocca
Nature Clinical Practice. Cardiovascular Medicine|December 21, 2006
Drug insight: aspirin resistance--fact or fashion?Carlo Patrono, Bianca Rocca
Diabetes Research and Clinical Practice|January 12, 2020
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspectiveBianca Rocca, Carlo Patrono
Research and Practice in Thrombosis and Haemostasis|June 7, 2021
Aspirin at 120: Retiring, recombining, or repurposing?Carlo Patrono, Bianca Rocca
Pageof 16